{"schema_version":"1","generated_at":"2026-11-02T11:51:25.419Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mehdi-moezi","json_url":"https://www.findmykol.com/kol/mehdi-moezi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mehdi-moezi","name":"Mehdi Moezi","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Fleming Island","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1053316190","openalex":"A5108867498"},"summary":"Mehdi Moezi is an Oncology physician. OpenAlex indexes 28 publications with 482 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":28,"cited_by_count":482,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":38,"program_years":{"first":2021,"last":null},"rows_total":66,"shown":3,"withheld":63,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":66.3,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053316190"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":48.77,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053316190"},{"payer":"GlaxoSmithKline, LLC.","program_year":2025,"amount_usd":40.48,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1053316190"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1053316190","source":"payments"},"publications":{"total":39,"shown":5,"withheld":34,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative ( <scp>HR</scp> +/ <scp>HER2</scp> −) Advanced Breast Cancer Treated With Palbociclib in the <scp>POLARIS</scp> Study","year":2026,"journal":"Cancer Medicine","source_url":"https://doi.org/10.1002/cam4.71788","status":"verified"},{"title":"Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2− advanced breast cancer: final results from the POLARIS trial","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyae291","status":"verified"},{"title":"A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone","year":2024,"journal":"Targeted Oncology","source_url":"https://doi.org/10.1007/s11523-024-01049-w","status":"verified"},{"title":"Osgood-Schlatter Disease in an Adult Athlete: A Case Report and Review of the Literature","year":2024,"journal":"Journal of Orthopedic and Spine Trauma","source_url":"https://doi.org/10.18502/jost.v10i3.16790","status":"verified"},{"title":"Chronic Patellar Tendon Rupture: Choice Between Two Allograft Reconstruction Techniques","year":2024,"journal":"JBJS Case Connector","source_url":"https://doi.org/10.2106/jbjs.cc.24.00080","status":"verified"}],"source":"works"},"contact":{"address_1":"2370 MARKET DR","city":"Fleming Island","state":"FL","zip":"320034326","phone":"094-264-6201","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1053316190","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":63,"publications":34}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2014-11-17","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}